Protein acetylation is mostly known for its role in chromatin remodeling. In this issue, Mi skiewicz and colleagues reveal a novel function of acetylation at the nerve terminal, where it regulates T bars and the number of associated synaptic vesicles to ultimately control the efficacy of synaptic transmission.
For almost 50 years, we have known that nuclear histones are modified by reversible acetylation (Allfrey et al., 1964) . Histone acetyl transferases (HATs) acetylate lysines in these proteins and thereby neutralize their positive charge, reduce their affinity for negatively charged DNA, and make DNA more accessible for transcription and transcriptional control (Figure 1) . Histone acetylation and deacetylation also play important roles in the nervous system, where acetylation is implicated in synaptic plasticity and memory formation. For instance, in Aplysia, the neurotransmitter serotonin activates histone acetylation in the promoter region of the immediate early gene C/EBP, which is necessary for synaptic facilitation (Guan et al., 2002) . This effect can be enhanced by inhibitors of deacetylases (HDACs, Figure 1 ). In rodents, HDAC inhibitors induce sprouting of dendrites, an increased synapse number, and improved performance in memory tasks (Fischer et al., 2007) . Not surprisingly, HDAC inhibitors are neuroprotective, and HDACs are candidate drug targets for the treatment of memory dysfunction and neurodegenerative diseases, such as Alzheimer's disease.
Recent studies suggest that HATs are also cytosolic, that many cytosolic proteins are also acetylated, and that this affects a wide range of cellular functions such as cytoskeletal dynamics, cellular transport, protein folding, and receptor signaling (Choudhary et al., 2009; Sadoul et al., 2011) . Elongator protein 3 (ELP3) is one such cytosolic HAT. It is the catalytic subunit of the six-subunit Elongator complex first described in yeast as a component of RNA polymerase II involved in transcription elongation in the nucleus (Otero et al., 1999) . ELP3 contains a histone acetyl transferase motif, and the Elongator complex indeed acetylates histones. However, most ELP3 is present in the cytosol, where it was implicated in tRNA modification (Svejstrup, 2007) .
Using forward genetic screens in Drosophila, elp3 recently surfaced in relation to synaptic function (Simpson et al., 2009) . In this issue of Neuron, Mi skiewicz et al. (2011) now present the first direct evidence for such a synaptic function at the fly neuromuscular junction (NMJ). The authors identify the first synapsespecific acetylation target, the active zone protein Bruchpilot (BRP), and, using the superb genetic tools available in Drosophila, present compelling evidence for the biological significance of ELP3-dependent acetylation at the presynaptic terminal. Furthermore, this study also produces evidence for an additional ELP3 function in regulating GluRIIA receptors at the postsynapse, though the mechanism for this novel role at the synapse has yet to be fully elucidated.
BRP is an integral part of the T bar, a morphological structure at fly NMJ active zones ( Figure 1 ). In brp null mutants, T bars are entirely lost, Ca 2+ -channel clustering is disturbed, and synaptic transmission is compromised (Kittel et al., 2006) . BRP proteins are considered to exist as parallel bundles juxtaposed to the active zone. Their N termini are close to the active zone, where they bind/ cluster calcium channels, and their C termini extend out into the cytoplasm, where they bind vesicles (Figure 1 ). The study by Mi skiewicz et al. (2011) demonstrates that ELP3 is present at synapses and that elp3 mutant alleles produce increased immunoreactivity for the C-terminal end of BRP. An increase in C-versus N-terminal BRP immunoreactivity in elp3 mutants suggests a morphological change in BRP rather than supernumerary BRP strands at the active zone. Therefore, the authors conclude that elp3 deletion does not affect T bar assembly per se but alters the morphology or accessibility of BRP's C terminus (Figure 1 ). Given these findings, the authors then tested whether BRP is a substrate for ELP3 acetylation. Indeed, BRP acetylation by ELP3 was demonstrated in vitro and in vivo, and electron micrographs revealed more pronounced T bar elongations in elp3 mutants. Moreover, in these mutants, more synaptic vesicles were found tethered at the active zone, and the efficiency of synaptic transmission was increased. Specifically, during repetitive stimulation, elp3 mutants released more quanta than controls, as assessed electrophysiologically and confirmed by independent imaging experiments of presynaptic release (synaptopHluorin fluorescence). This phenotype was also observed in mutant animals that express ELP3 only on the postsynaptic side, confirming the presynaptic location of ELP3 actions. These are crucial findings that really demonstrate a significant role of ELP3 in presynaptic function.
Cumulative plots of the electrophysiological data suggest that a larger pool of synaptic vesicles immediately available for fusion (i.e., the readily releasable pool, RRP) explains the enhanced synaptic transmission in the elp3 mutants. The RRP was estimated to be approximately 700 vesicles in control NMJs and 900 in elp3 mutants. The authors carefully avoid making strong claims about an increased RRP size, because RRP is not as precisely defined/validated in NMJs as in some mammalian model synapses, and a larger release probability may also contribute to the elp3 phenotype. Nevertheless, the observed increase in RRP size is an unusual phenotype, because many published genetic perturbations that affect presynaptic function alter the release probability rather than RRP size (although see Toonen et al., 2006 for exceptions) . This unusual effect of ELP3 deletion on the RRP size deserves further study, beyond the Drosophila NMJ. Synaptic vesicle release is proposed to occur from a limited number of release sites that are rate limiting during intense activity.
However, the identity and organization of these release sites is still poorly defined, and it is unknown if and/or how the number of such sites can be regulated by activity. BRP acetylation may negatively regulate accessibility of release sites analogous to how histone acetylation positively regulates accessibility of DNA. The reported RRP increase in elp3 mutants might also be a valuable starting point to find new therapeutic directions for neurodegenerative diseases in which synapses have become pathologically weak (see discussion in Toonen et al., 2006) . Mammalian CNS synapses do not possess a T bar, and it remains to be determined whether ELP3 similarly regulates synaptic functions at mammalian synapses. However, known links between ELP3 and amyotrophic lateral sclerosis (Simpson et al., 2009 ) and between HDACs and memory formation (Fischer et al., 2007) certainly justify further studies in this direction.
It also remains to be determined how synaptic vesicles tether to the T bar, how acetylation of BRP inhibits this process, and how these events contribute to the regulation of RRP size. Flies expressing the brp nude allele, which encodes BRP with a 17 amino acid C-terminal truncation, have no vesicles clustered at their T bars (Hallermann et al., 2010) . This suggests that the far C terminus is essential for vesicle association. This fragment contains a single lysine (Hallermann et al., 2010) , and it is therefore conceivable that this lysine is a primary site of ELP3 acetylation. In brp nude mutants and even in brp null mutants, vesicles still dock at the plasma membrane and synaptic transmission is not completely abolished while T bars are lost and Ca 2+ -channel clusters are disturbed. Importantly, in brp nude mutants, RRP size is normal (Hallermann et al., 2010) . Hence, RRP size and synaptic transmission do not depend on T bars, and the relatively strong defects in synaptic transmission in the brp null mutants may be due to loss of Ca 2+ channels or other factors rather than the loss of T bars. Hence, T bar associated vesicles might not contribute to the true RRP but may supply vesicles that are formally not ''readily releasable'' but can be rapidly recruited during repetitive stimulation. The observed increase in synaptic transmission during repetitive stimulation in elp3 mutants and the concomitant increase in vesicle clustering at the T bar are consistent with this idea.
The elp3 phenotype is not as strong as in mutants in which constituents of the secretion machinery are deficient. It is clear that ELP3-dependent acetylation/ deacetylation is not an indispensible factor for synapse formation or neurotransmission but rather a type of regulation that modulates synaptic transmission by 20%-30%, similar to several other posttranslational modifications such as phosphorylation, ubiquitination, and sumoylation. Nevertheless, under conditions of reduced release probability (low extracellular Ca 2+ ) or reduced postsynaptic receptor sensitivity (competitive receptor antagonist), the role of ELP3-dependent acetylation was demonstrated beyond doubt and the impact on synaptic transmission was substantial. Because the elp3 mutant phenotype is essentially a gain of function, acetylation under normal physiological conditions probably exerts an inhibitory effect on presynaptic function and neurotransmission. This is in contrast to the known consequences of acetylation in the nucleus, where acetylation is generally considered to promote transcriptional activity (Figure 1 ). Hence, acetylation appears to act in an opposite manner between synapse and nucleus. The temporal dynamics of protein acetylation and deacetylation at the synapse are unknown, and BRP might be deacetylated in a regulated manner. Given the elp3 phenotype, a large proportion of BRP is probably acetylated in naive NMJs.
Regulated deacetylation of BRP can be an effective mechanism to regulate synaptic strength. However, it is not known which deacetylating enzymes are expressed in the presynaptic terminal and whether these (and/or ELP3) are regulated in an activity-dependent manner. Interestingly, Calmodulin kinase II and protein kinase D-dependent phosphorylation shuttle HDAC4 and HDAC5 from the nucleus to the cytosol (reviewed in Fischer et al., 2010) . Such enzymes might also translocate in axons and locally deacetylate synaptic targets. A recent proteomics study shows that ELP3 is also ubiquitinated (Kim et al., 2011) , which provides an additional means to control ELP3 activity and thereby synaptic strength. In addition to BRP, other synaptic proteins might be acetylation substrates. In principle, synaptic protein acetylation could be as important for synaptic transmission as phosphorylation and ubiquitination. Mi skiewicz et al. identified BRP as a target for acetylation using a candidate approach. However, more open screens in the future, for instance using proteomic approaches, will be critical to probe the full synaptic ''acetylome.''
